Tumor Cell Membrane (via Accumulation) (TCM (Accumulation))

The tumor cell membrane is the outer boundary of cancer cells, composed primarily of a lipid bilayer interspersed with proteins, glycoproteins, and other molecules. It plays a critical role in cellular communication, adhesion, signaling, and the regulation of substance transport into and out of the cell. Targeting the tumor cell membrane, particularly via accumulation strategies, aims to exploit unique features of the membrane to achieve selective accumulation or retention of therapeutic agents within tumors. This includes utilizing the EPR effect, active targeting with ligands binding to overexpressed receptors, and homotypic targeting with cell-membrane-coated nanoparticles.

Other names

Cancer Cell MembraneTumor MembraneModified Cancer Cell MembraneEPR TargetHomotypic Targeting Site

Accumulation of therapeutic agents within the tumor microenvironment via passive (EPR effect), active (ligand-receptor binding), or homotypic targeting mechanisms. Modulation of membrane composition to enhance drug uptake or overcome drug resistance.